These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15375020)

  • 1. Macrophage-mediated cardiac fibrosis.
    Schulze PC; Lee RT
    Circ Res; 2004 Sep; 95(6):552-3. PubMed ID: 15375020
    [No Abstract]   [Full Text] [Related]  

  • 2. Overexpression of urokinase by macrophages or deficiency of plasminogen activator inhibitor type 1 causes cardiac fibrosis in mice.
    Moriwaki H; Stempien-Otero A; Kremen M; Cozen AE; Dichek DA
    Circ Res; 2004 Sep; 95(6):637-44. PubMed ID: 15297377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis.
    Heymans S; Pauschinger M; De Palma A; Kallwellis-Opara A; Rutschow S; Swinnen M; Vanhoutte D; Gao F; Torpai R; Baker AH; Padalko E; Neyts J; Schultheiss HP; Van de Werf F; Carmeliet P; Pinto YM
    Circulation; 2006 Aug; 114(6):565-73. PubMed ID: 16880329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of macrophage-derived urokinase plasminogen activator in myocardial infarct repair: urokinase attenuates ventricular remodeling.
    Minami E; Castellani C; Malchodi L; Deem J; Bertko K; Meznarich J; Dishmon M; Murry CE; Stempien-Otero A
    J Mol Cell Cardiol; 2010 Sep; 49(3):516-24. PubMed ID: 20380835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory pathways and cardiac repair: the affliction of infarction.
    Knowlton KU; Chien KR
    Nat Med; 1999 Oct; 5(10):1122-3. PubMed ID: 10502807
    [No Abstract]   [Full Text] [Related]  

  • 6. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host.
    Szalay G; Sauter M; Haberland M; Zuegel U; Steinmeyer A; Kandolf R; Klingel K
    Circ Res; 2009 Apr; 104(7):851-9. PubMed ID: 19246678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling.
    Weisberg AD; Albornoz F; Griffin JP; Crandall DL; Elokdah H; Fogo AB; Vaughan DE; Brown NJ
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):365-71. PubMed ID: 15576638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An unexpected role of plasminogen activator inhibitor-type 1 (PAI-1) in renal fibrosis.
    Huang Y; Noble N
    Kidney Int; 2005 Jun; 67(6):2502-3. PubMed ID: 15882299
    [No Abstract]   [Full Text] [Related]  

  • 9. The plasminogen-MMP system is more activated in the scar than in viable myocardium 3 months post-MI in the rat.
    Gaertner R; Jacob MP; Prunier F; Angles-Cano E; Mercadier JJ; Michel JB
    J Mol Cell Cardiol; 2005 Jan; 38(1):193-204. PubMed ID: 15623436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activators and inhibitor type-1 in alveolar osteitis.
    Serratì S; Margheri F; Bruschi S; D'Alessio S; Pucci M; Fibbi G; Tonelli P; Del Rosso M
    Eur J Oral Sci; 2006 Dec; 114(6):500-3. PubMed ID: 17184232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic expression of matrix metalloproteinase-1 inhibits myocardial fibrosis and prevents the transition to heart failure in a pressure overload mouse model.
    Foronjy RF; Sun J; Lemaitre V; D'Armiento JM
    Hypertens Res; 2008 Apr; 31(4):725-35. PubMed ID: 18633185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers.
    Weckroth M; Vaheri A; Virolainen S; Saarialho-Kere U; Jahkola T; Sirén V
    Br J Dermatol; 2004 Dec; 151(6):1189-96. PubMed ID: 15606514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance increases PAI-1 in the heart.
    Sobel BE; Schneider DJ; Lee YH; Pratley RE
    Biochem Biophys Res Commun; 2006 Jul; 346(1):102-7. PubMed ID: 16750510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mactinin treatment promotes wound-healing-associated inflammation in urokinase knockout mice.
    Luikart SD; Levay-Young B; Hinkel T; Shearer J; Mills C; Caldwell MD; Gyetko MR; Oegema TR
    Wound Repair Regen; 2006; 14(2):123-8. PubMed ID: 16630100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction.
    Timmers L; van Keulen JK; Hoefer IE; Meijs MF; van Middelaar B; den Ouden K; van Echteld CJ; Pasterkamp G; de Kleijn DP
    Circ Res; 2009 Mar; 104(5):699-706. PubMed ID: 19168865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of urokinase-type plasminogen activator (uPA) and transforming growth factor beta 1 (TGFbeta1) in muscle regeneration.
    Philippou A; Maridaki M; Koutsilieris M
    In Vivo; 2008; 22(6):735-50. PubMed ID: 19181000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice.
    Matsumura S; Iwanaga S; Mochizuki S; Okamoto H; Ogawa S; Okada Y
    J Clin Invest; 2005 Mar; 115(3):599-609. PubMed ID: 15711638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of sympathetic activity by tissue plasminogen activator is independent of plasminogen and urokinase.
    Schaefer U; Vorlova S; Machida T; Melchor JP; Strickland S; Levi R
    J Pharmacol Exp Ther; 2007 Jul; 322(1):265-73. PubMed ID: 17429057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urokinase plasminogen activator upregulates paraoxonase 2 expression in macrophages via an NADPH oxidase-dependent mechanism.
    Fuhrman B; Khateeb J; Shiner M; Nitzan O; Karry R; Volkova N; Aviram M
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1361-7. PubMed ID: 18436804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MRL mouse heart does not recover ventricular function after a myocardial infarction.
    Cimini M; Fazel S; Fujii H; Zhou S; Tang G; Weisel RD; Li RK
    Cardiovasc Pathol; 2008; 17(1):32-9. PubMed ID: 18160058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.